EVOK: Evoke Pharma, Inc. Company Short-Term Debt

Symbol and logo of brand Evoke Pharma, Inc (EVOK)

Evoke Pharma, Inc. (EVOK) is focused on the commercialization of Gimoti, offering a convenient alternative to tablets for patients with absorption issues. This biopharmaceutical startup has developed an effective nasal drug delivery method to combat nausea. The linear price action on the GURU.Markets chart, where the indicator stands at 0.01, underscores a growth strategy driven by patent acquisitions and partnerships with major distributors.

EVOK (Evoke Pharma Inc.) Company Short-Term Debts history from 07/04/2022 to 12/27/2025

Analytical breakdowns for Evoke Pharma, Inc.

- current quotes and average value forecast:
Price Chart Evoke Pharma|EVOK - Fair Value Consensus
- market capitalization information:
Market Value Evoke Pharma, Inc.|EVOK - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Evoke Pharma|EVOK - Book Capitalization|Market Cap to Net Assets Ratio evokepharma.com|EVOK - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Evoke Pharma, Inc.|EVOK - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Evoke Pharma, Inc.|EVOK - Company Total Debt Obligations|Debt to Book Value Evoke Pharma, Inc.|EVOK - Amount of Long-Term Liabilities|Company Short-Term Debts Evoke Pharma|Quick Liquidity Indicator evokepharma.com
- net income and valuation multiples indicators:
EVOK - Company Net Income
Fundamental company analysis:Evoke Pharma - EVOK
Manufactured products of Evoke Pharma Inc

Short-term debt measures the volume of urgent obligations, determining the level of operational liquidity and the risk of forced asset liquidation to settle loans. By analyzing the current volume of short-term borrowings, an investor assesses the solvency of the business, which in the case of Evoke Pharma, Inc. (EVOK) is supported by a steady cash flow from the sale of specialized nasal sprays, minimizing the company's reliance on external borrowing.

Who Evoke Pharma, Inc. competes with

PHAT - Company Short-Term Debt|Company Short-Term Loans and Borrowings TERN (Terns Pharma)|ironwoodpharma.com (IRWD) - Company Short-Term Debt|Company Current Liabilities Curanex Pharmaceuticals|IMRN (Immuron Ltd) - Company Short-Term Debts|Company Short-Term Debts Entero|Company Current Liabilities RDHL (RedHill Biopharma)|PALI (palisadebio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts JAGX (Jaguar Animal Health)|Short-Term Indebtedness Biora Therapeutics, Inc|Morphic Holding, Inc. - Company Short-Term Debts